If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed ...

SYNLAB Vet becomes part of Mars Petcare's Science Diagnostics division to provide diagnostics and technology to more veterinary professionals and pets in Europe Mars, Incorporated ("Mars") today ...

Shareholders will be ecstatic, with their stake up 35% over the past week following SYNLAB AG's (FRA:SYAB) latest full-year results. Statutory earnings per share fell badly short of expectations, ...

SYNLAB AG (“SYNLAB” or “the Group”, FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, today announced its audited FY 2023 results. The Group reports robust ...

COPENHAGEN (Reuters) - Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro (212.43 million pounds) subscription to ...

- H1'21 adjusted EBITDA of EUR 663 million compared to EUR 679 million for FY'20 - H1'21 record unlevered FCF of EUR 428 million driving major leverage ratio reduction to 1.4x - On track to exceed ...

Synlab Italia has suspended all its medical diagnostic and testing services after a ransomware attack forced its IT systems to be taken offline. Part of the Synlab group that is present in 30 ...

Cinven has agreed to sell a minority stake in Synlab, a medical diagnostic services and specialty testing provider, to financial investor Elliott Advisors (UK). Munich-based Synlab provides a full ...

Laboratory services group Synlab has priced its initial public offering at 18 euros ($21.76) a share, it said on Tuesday, marking the lower end of a pricing range due to sluggish investor demand.

FRANKFURT (Reuters) - Europe's largest lab operator Synlab could extend its lead with acquisitions after wrapping up a debt deal worth close to 1 billion euros ($1.1 billion), it said on Friday. "We ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Success does not always breed success. Some pandemic winners rushing to float are grabbing shortlived gains.

Cinven has agreed to sell an indirect minority stake in Synlab, a medical diagnostic services and specialty testing provider in Europe, to Labcorp. The purchase price for this 15 percent stake was ...